Ad
Friday, 26 October 2018
Abbott, AbbVie settle U.S. case over TriCor marketing for $25 million
Abbott Laboratories and AbbVie Inc will pay $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for them prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment